Email this article 
Efficiency and safety of levoсabastine (TYZINE®ALERGY) in allergic rhinitis patients
- Authors: Elisyutina OG1, Shtyrbul OV1, Ilina NI1
-
Affiliations:
- Institute of Immunology
- Issue: Vol 12, No 1 (2015)
- Pages: 65-72
- Section: Articles
- URL: https://rusalljournal.ru/raj/article/view/503
- DOI: https://doi.org/10.36691/RJA503
- ID: 503
Cite item
Open Access
Access granted
Abstract
Own results of clinical observation about application of levoсabastine in complex therapy of allergic rhinitis are presented in the article
Keywords
Full Text
About the authors
O G Elisyutina
Institute of Immunology
Email: el-olga@yandex.ru
Moscow, Russia
O V Shtyrbul
Institute of ImmunologyMoscow, Russia
N I Ilina
Institute of ImmunologyMoscow, Russia
References
- Аллергология. Федеральные клинические рекомендации. Под ред. Р.М. Хаитова, Н.И. Ильиной. M., «Фармарус Принт Медиа». 2014, 126 с.
- Bousquet J., Khaltaev N., Cruz A.A. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008, v. 86, p. 8-160.
- Falser N., Wober W., Rahlfs V.W., Baehre M. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis. Arzneimittelforschung. 2001, v. 51, p. 387-393.
- Canonica W.G., Marzetto M., Kolb С., Ellers-Lenz B. Multinational clinical trial to assess efficacy and safety of azelastine eye drops in patients with perennial allergic conjunctivitis/rhino-conjunctivitis. Annual Meeting of the European Academy of Allergology and Clinical Immunology. 2000, p. 662.
- Kremer B., Tündermannb A., Goldschmidt O. et al. Effectiveness and Tolerance of Levocabastine and Nedocromil in Topical Therapy of Seasonal Allergic Rhinoconjunctivitis. Armeim. Forsch. Drug. Res. 1998, v. 48, p. 924-930.
- Gerth van Wijk R. Treatment of allergic rhinoconjunctivitis a review of the role of topical levocabastine. Mediators of Inflammation. 1995, v. 4, p. 31-38.
Supplementary files
